111 studies found for:    aspirin | United States, New York | Studies with Male Participants
Show Display Options
Rank Status Study
21 Recruiting Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
22 Recruiting Antiplatelet Therapy in HIV
Conditions: HIV;   Cardiovascular Diseases;   Inflammation
Interventions: Drug: Aspirin;   Drug: Clopidogrel
23 Active, not recruiting
Has Results
A Phase III Study of Apixaban in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Apixaban;   Drug: Acetylsalicylic acid
24 Active, not recruiting A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: rivaroxaban 2.5 mg;   Drug: rivaroxaban 15 mg;   Drug: rivaroxaban 10 mg;   Drug: aspirin (ASA);   Drug: vitamin K antagonist (VKA);   Drug: clopidogrel;   Drug: prasugrel;   Drug: ticagrelor
25 Completed Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine
Conditions: Common Cold;   Pharyngitis
Interventions: Drug: Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine;   Drug: Acetylsalicylic Acid (Aspirin, BAYE4465);   Drug: Pseudoephedrine;   Drug: Placebo
26 Recruiting Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Warfarin 1mg
27 Recruiting Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)
Conditions: High Risk Polycythemia Vera;   High Risk Essential Thrombocythemia
Interventions: Drug: PEGASYS;   Drug: Hydroxyurea;   Drug: Aspirin
28 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
29 Active, not recruiting
Has Results
MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Pomalidomide;   Drug: Dexamethasone;   Drug: Aspirin
30 Completed Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
31 Active, not recruiting
Has Results
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Coronary Stent System;   Device: PROMUS Element Coronary Stent System;   Drug: Aspirin;   Drug: Thienopyridine
32 Completed
Has Results
PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
Condition: Stroke
Interventions: Drug: Aggrenox;   Drug: Clopidogrel placebo;   Drug: Micardis;   Drug: Aggrenox placebo;   Drug: Clopidogrel;   Drug: Micardis placebo
33 Active, not recruiting PROMUS Element Plus US Post-Approval Study
Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus Coronary Stent System;   Drug: Aspirin;   Drug: P2Y12 antagonist
34 Recruiting Etanercept in Kawasaki Disease
Conditions: Mucocutaneous Lymph Node Syndrome;   Kawasaki Disease
Interventions: Drug: Etanercept;   Drug: Placebo
35 Completed
Has Results
The Effects of Omega-3 Fatty Acids on Aspirin Resistance
Condition: Increased Drug Resistance
Interventions: Drug: Aspirin;   Drug: Lovaza;   Drug: Both Aspirin and Lovaza;   Other: Placebo
36 Recruiting Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes
Conditions: Peripheral Artery Disease;   Type 2 Diabetes
Interventions: Drug: Aspirin;   Drug: Ticagrelor;   Drug: Aspirin Placebo;   Drug: Ticagrelor Placebo
37 Completed Fish Oil and Aspirin With Type 2 Diabetes
Condition: Cardiovascular Disease
Intervention: Dietary Supplement: Fish Oil and Aspirin
38 Completed Warfarin Versus Aspirin Recurrent Stroke Study
Condition: Stroke
Interventions: Drug: Active Aspirin;   Drug: Active Warfarin;   Drug: Aspirin placebo;   Drug: Warfarin placebo
39 Recruiting Ticagrelor With Aspirin or Alone in High-Risk Patients After Coronary Intervention
Conditions: Cardiovascular Disease;   Interventional Cardiology
Interventions: Drug: Aspirin;   Drug: Placebo;   Drug: ticagrelor
40 Active, not recruiting Aspirin in Reducing Events in the Elderly
Conditions: Functional Disability;   Dementia;   Heart Disease;   Stroke;   Cancer;   Bleeding;   Depression
Interventions: Drug: 100 mg enteric-coated aspirin;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years